Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-802, South Korea
NCT Number: NCT01781065
The purpose of this study is to evaluate the analgesic effect of transcranial direct current stimulation (tDCS) applied on motor cortex in patients with spinal cord injury who have chronic neuropathic pain.
Looking for future studies?
Notify Me30 year–60 year
All sexes
Interventional
Phase 2
Seongnam-si, Gyeonggi-do, 463-802, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Iomed Phoresor II Auto
Time frame: before the first tDCS session, and 1, 2, 4, 6 and 8 wk after the start of the stimulation
Time frame: before the first tDCS session, and 1, 2, 4, 6, and 8 wk after the start of the stimulation
Time frame: before the first tDCS session, and 1, 2, 4, 6, 8 wk after start of the stimulation
Seoul National University Bundang Hospital
Other
The Analgesic Effect of Transcranial Direct Current Stimulation Over the Primary Motor Cortex on Central Neuropathic Pain Patients With Spinal Cord Injury
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01884662
Central Nervous System Diseases, Nervous System Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT01599767
Central Nervous System Diseases, Chronic Pain
Boston, Massachusetts, United States
View Trial DetailsNCT01037088
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Sacramento, California, United States
View Trial DetailsNCT00488969
Central Nervous System Diseases, Chronic Pain
New York, United States
View Trial Details